ad image

Kidney Disease

1 / 1
Ascelia Pharma
Kidney Disease

Ascelia Pharma Meets Major Milestone with Patient Enrollment Completion of Phase 3 Study for Orviglance, Novel MRI Contrast Agent for Patients with Kidney Impairment

Ascelia Pharma

PR-M02-23-04Feb 27, 2023
Baxter
Collaboration

Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease

Baxter

PR-M05-18-NI-025May 07, 2018
1 / 1